It is noteworthy that several LUSC samples were negative for β2M and HLA, which suggests that those tumors might escape from tumor-recognizing immune cells by losing antigen presentation through loss of HLA expression (Table 1 and Supplemental Figure 3). The gene discussed is B2M; the disease is neoplasm.